FI883589A - Menetelmä tyydyttämättömien aminohappoyhdisteiden valmistamiseksi - Google Patents

Menetelmä tyydyttämättömien aminohappoyhdisteiden valmistamiseksi Download PDF

Info

Publication number
FI883589A
FI883589A FI883589A FI883589A FI883589A FI 883589 A FI883589 A FI 883589A FI 883589 A FI883589 A FI 883589A FI 883589 A FI883589 A FI 883589A FI 883589 A FI883589 A FI 883589A
Authority
FI
Finland
Prior art keywords
preparation
amino acid
acid compounds
unsaturated amino
unsaturated
Prior art date
Application number
FI883589A
Other languages
English (en)
Swedish (sv)
Other versions
FI94415B (fi
FI94415C (fi
FI883589A0 (fi
Inventor
Hans Allgeier
Christof Angst
Guido Bold
Rudolf Duthaler
Roland Heckendorn
Antonio Togni
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI883589A0 publication Critical patent/FI883589A0/fi
Publication of FI883589A publication Critical patent/FI883589A/fi
Publication of FI94415B publication Critical patent/FI94415B/fi
Application granted granted Critical
Publication of FI94415C publication Critical patent/FI94415C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/16Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165Esters of thiophosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/48Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof
    • C07F9/4808Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof the acid moiety containing a substituent or structure which is considered as characteristic
    • C07F9/4825Acyclic unsaturated acids or derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/302Acyclic unsaturated acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3826Acyclic unsaturated acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI883589A 1987-08-04 1988-08-01 Menetelmä tyydyttämättömien aminohappoyhdisteiden valmistamiseksi FI94415C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH298687 1987-08-04
CH298687 1987-08-04

Publications (4)

Publication Number Publication Date
FI883589A0 FI883589A0 (fi) 1988-08-01
FI883589A true FI883589A (fi) 1989-02-05
FI94415B FI94415B (fi) 1995-05-31
FI94415C FI94415C (fi) 1995-09-11

Family

ID=4246086

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883589A FI94415C (fi) 1987-08-04 1988-08-01 Menetelmä tyydyttämättömien aminohappoyhdisteiden valmistamiseksi

Country Status (16)

Country Link
EP (1) EP0302826A3 (fi)
JP (2) JP2714018B2 (fi)
KR (1) KR970011164B1 (fi)
AU (1) AU605340B2 (fi)
CA (1) CA1328113C (fi)
DD (1) DD282016A5 (fi)
DK (1) DK434788A (fi)
FI (1) FI94415C (fi)
HU (1) HU202242B (fi)
IL (1) IL87246A (fi)
NO (1) NO172495C (fi)
NZ (1) NZ225649A (fi)
PH (1) PH27591A (fi)
PT (1) PT88170B (fi)
YU (1) YU150188A (fi)
ZA (1) ZA885653B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175344A (en) * 1986-02-13 1992-12-29 Ciba-Geigy Corporation Unsaturated amino acids
EP0391850B1 (de) * 1989-04-07 1994-09-28 Ciba-Geigy Ag Ungesättigte Aminodicarbonsäurederivate
US5294734A (en) * 1989-09-26 1994-03-15 Ciba-Geigy Corp. 4-substituted 2-aminoalk-3-enoic acids
US5488140A (en) * 1989-09-26 1996-01-30 Ciba-Geigy Corporation 4-substituted 2-aminoalk-3-enoic
DK0420806T3 (da) * 1989-09-26 1995-10-16 Ciba Geigy Ag Phosphonsyrer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
US7414086B2 (en) 2005-05-13 2008-08-19 Shin-Etsu Chemical Co., Ltd. Room temperature-curable organopolysiloxane compositions
US20090170813A1 (en) * 2005-10-18 2009-07-02 Francine Acher Hypophosphorous Acid Derivatives and their Therapeutical Applications
JP4952952B2 (ja) 2008-09-12 2012-06-13 信越化学工業株式会社 室温硬化性オルガノポリシロキサン組成物の製造方法
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE70535T1 (de) * 1986-02-13 1992-01-15 Ciba Geigy Ag Ungesaettigte aminosaeuren.

Also Published As

Publication number Publication date
ZA885653B (en) 1989-04-26
YU150188A (en) 1990-04-30
HUT47947A (en) 1989-04-28
NO172495B (no) 1993-04-19
EP0302826A2 (de) 1989-02-08
HU202242B (en) 1991-02-28
FI94415B (fi) 1995-05-31
PT88170A (pt) 1989-06-30
PH27591A (en) 1993-08-31
JPH1053597A (ja) 1998-02-24
KR890003786A (ko) 1989-04-18
IL87246A0 (en) 1989-03-31
NO172495C (no) 1993-07-28
DK434788D0 (da) 1988-08-03
EP0302826A3 (de) 1991-04-03
PT88170B (pt) 1995-03-01
JPH0248586A (ja) 1990-02-19
NO883444L (no) 1989-02-06
DK434788A (da) 1989-02-05
KR970011164B1 (ko) 1997-07-08
FI94415C (fi) 1995-09-11
NO883444D0 (no) 1988-08-03
AU2038988A (en) 1989-03-02
JP2714018B2 (ja) 1998-02-16
IL87246A (en) 1996-07-23
NZ225649A (en) 1991-05-28
CA1328113C (en) 1994-03-29
FI883589A0 (fi) 1988-08-01
DD282016A5 (de) 1990-08-29
AU605340B2 (en) 1991-01-10

Similar Documents

Publication Publication Date Title
PT87754A (pt) Process for the preparation of new amino acid derivatives
FI882638A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten booriaminohappojohdannaisten valmistamiseksi
FI892881A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten aminohappojohdannaisten va lmistamiseksi
FI882007A (fi) Menetelmä steroidi-5- -reduktaasin inhibiittorien valmistamiseksi
FI860484A (fi) Menetelmä terapeuttisesti aktiivisten peptidijohdannaisten valmistamiseksi
FI883064A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
DE3366919D1 (en) Bicyclic amino acid derivatives, process for their preparation, agents containing them and their application, bicyclic amino acids as intermediates, and process for their preparation
FI90769C (fi) Menetelmä terapeuttisesti käyttökelpoisten triatsoliyhdisteiden valmistamiseksi
PT87153A (pt) Process for the preparation of acid ribofuranuronic derivatives
FI881303A0 (fi) Menetelmä ibuprofeenin valmistamiseksi
FI883997A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-fenyyli-4-kinoliinikarboksyylihappojen valmistamiseksi
FI884471A0 (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI883589A (fi) Menetelmä tyydyttämättömien aminohappoyhdisteiden valmistamiseksi
PT88545A (pt) Process for the manufacture of benzimidazoline-2-oxo-1-carboxylic acid derivative compounds
PT87857A (pt) Process for the preparation of novel immunossupressant peptides
FI92188C (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
FI89062C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara somatostatinanaloger
FI885045A (fi) Menetelmä polynukleotidien valmistamiseksi
FI863282A0 (fi) Uusi menetelmä valmistaa metyleenidioksifenantreeniyhdisteitä
FI90658C (fi) Menetelmä terapeuttisesti käyttökelpoisen (E)-2-(p-fluorifenetyyli)-3-fluoriallyyliamiinin valmistamiseksi
HRP940444A2 (en) Process for the preparation of unsaturated amino acid compounds
FI933175A0 (fi) Menetelmä optisesti aktiivisten -aryylialkaanikarboksyylihappojen valmistamiseksi
EG18418A (en) Process for the preparation of novel 2-thienyloxacetic acid derivatives
NO180296C (no) Fremgangsmåte for fremstilling av cykliske aminosyre-forbindelser

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MM Patent lapsed
MM Patent lapsed

Owner name: NOVARTIS AG